A new study suggests CBD could play a role in fighting antibiotic-resistant bacteria. Many U.S. cannabis advocates say it’s further evidence that legal barriers to cannabis research need to come down — and fast.
Amid all the utopian sensationalism about the supposedly salubrious properties of the cannabinoid CBD, some are...
CANADA, February 4, 2020 (HEMPINDUSTRY) Editor’s note: This is part of an occasional series on retailing trends in the hemp industry.
Canada’s federal health regulator is reviewing the potential market for cannabis health products that would not require physician oversight, a review that...
U.S, February 11, 2020 (ANALYTICALCANNABIS) Memories aren’t always trustworthy, especially, it seems, when cannabis is involved.
In a new study published this Monday, researchers found that people can double their number of “false memories” after inhaling marijuana fumes. In a series of virtual...
UNITED KINGDOM, October 9, 2019, (HEALTH EUROPA) - Zelda Therapeutics Limited has announced a proposed merger of equals with Ilera Therapeutics LLC (Ilera Therapeutics).
Ilera Therapeutics is a privately held medical cannabis and cannabinoid science company based in the United States and, subject to approval from Zelda shareholders and all conditions of sale being met,...
AUSTRALIA, Ocotber 8, 2019, (CANNABISNOW) In the decades since the medical marijuana movement began in earnest in the 1970s, cannabis has been anecdotally touted as an effective treatment for a variety of illnesses, including those impacting brain function, such as seizures, anxiety and depression. However, peer-reviewed research into the...
AUSTRALIAN, January 21, 2020 (HEMPGAZETTE) There’s a lot of activity on the Australian cannabusiness scene, but what is happening at the patient end of things? Statistics from the Therapeutic Goods Administration (TGA) indicate significant growth in approvals, but it wouldn’t even be touching the sides of potential...